News
Head of Global PCR, Enzymes & Oligos at QIAGEN. "Our new QIAprep& Plasmodium Kit and assays allow researchers to monitor disease prevalence through high-frequency screening so they can better ...
Venlo, the Netherlands, April 6, 2025 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announces preliminary Q1 2025 results that exceed the outlook for both net sales and adjusted earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback